spacer
home > epc > Winter 2018
PUBLICATIONS

European Pharmaceutical Contractor

epc
Winter 2018

   
Text
PDF
bullet
Central Labs
Good Laboratory Practices

Ticking Boxes

Having a comprehensive checklist of Good Laboratory Practices within immuno-oncology trials can simplify study processes, as Elizabeth Koury and Jeff Mayhew at LabConnect suggest.
 
view
download pdf
Biomarkers and Assay Development

Marking Safety

New biomarkers are being evaluated as a promising solution to the threat of sepsis, as Professor Christene Leiper at Onorach explores.
 
view
download pdf
Central Laboratory Competencies

Smooth Sailing

Dr Sarah Waelde and Dr Holger Schoeneborn at SYNLAB pharma institute discuss the importance of maintaining Good Clinical Practice throughout the clinical trial process.
 
view
download pdf
bullet
Outsourcing
Equipment Rental Considerations
Healthy Hiring

Robin Salter at KWIPPED and Valere Horath at Quipment explain what considerations need to be made when renting equipment for a clinical trial.

 
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

White Papers

Working Towards a Standardised Identification Solution

PCI Pharma Services

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >>

Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement